Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling

Lichtenfels, M., Lorenzi, N. P. C., Tacla, M., Yokochi, K., Frustockl, F. C., Silva, C. A., da Silva, A. L., Termini, L., & de Farias, C. B. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1770134 · Cited by 10

Distribution of HPV Types in Tumor Tissue from Non-Vaccinated Women with Cervical Cancer in Norway

Sørbye, S. W., Falang, B. M., & Antonsen, M. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4030015 · Cited by 10

Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV

Li, X., Xiang, F., Zhao, Y., Li, Q., Gu, Q., Zhang, X., Chen, Z., Zhang, M., Wang, J., Liu, R., et al. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02538-2 · Cited by 10

Post-conization surveillance in an organized cervical screening program with more than 23,000 years of follow-up

Sundqvist, A., Nicklasson, J., Olausson, P. L., & Borgfeldt, C. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00545-4 · Cited by 11

Cervical Cancer Screening in the United States–Affiliated Pacific Islands

Waxman, A. G., Buenconsejo-Lum, L. E., Cremer, M., Feldman, S., Ault, K. A., Cain, J. M., & Diaz, M. L. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000161 · Cited by 11

Agreement of self- and physician-collected samples for detection of high-risk human papillomavirus infections in women attending a colposcopy clinic in Thailand

Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Sricharunrat, T., Teerayathanakul, N., Taepisitpong, C., Sornsamdang, G., Krongthong, W., & Saeloo, S. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3241-9 · Cited by 10

Evaluation of the Burden of HPV-Related Hospitalizations as a Useful Tool to Increase Awareness: 2007–2017 Data from the Sicilian Hospital Discharge Records

Restivo, V., Costantino, C., Amato, L., Candiloro, S., Casuccio, A., Maranto, M., Marrella, A., Palmeri, S., Pizzo, S., Vitale, F. M., et al. (2020) · Vaccines · doi:10.3390/vaccines8010047 · Cited by 10

A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers

Castle, P. E., Pierz, A. J., Adcock, R., Aslam, S., Basu, P. S., Belinson, J. L., Cuzick, J. M., El‐Zein, M., Catterina Ferreccio, R., Firnhaber, C. S., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0182 · Cited by 10

Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

Zhao, D., Zhang, L., Xie, F., Peng, D., Wei, J., Jiang, L., Zhang, S., & Qi, D. (2020) · BMC Cancer · doi:10.1186/s12885-020-07321-2 · Cited by 10

Triage human papillomavirus testing for cytology-based cervical screening in women of different ages in primary hospitals

Zhang, Y., Xu, X., Zhang, D., Wu, J., & Zhang, H. (2020) · Medicine · doi:10.1097/md.0000000000022320 · Cited by 10

The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia

Jansen, E. E. L., Ivanuš, U., Jerman, T., de Koning, H. J., & de Kok, I. M. C. M. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.10.036 · Cited by 10

Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China

Song, F., Belinson, J. L., Yan, P., Huang, X., Wang, C., Du, H., Qu, X., & Wu, R. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.05.014 · Cited by 10

Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China

Thomsen, L. T., & Kjær, S. K. (2021) · BMC Medicine · doi:10.1186/s12916-021-02051-z · Cited by 10

Ensuring a Successful Transition From Cytology to Human Papillomavirus–Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women’s Intentions: Protocol for an Observational Study

Griffin-Mathieu, G., Haward, B., Tatar, O., Zhu, P., Perez, S., Shapiro, G. K., McBride, E., Thompson, E. L., Smith, L., Lofters, A., et al. (2022) · JMIR Research Protocols · doi:10.2196/38917 · Cited by 10

Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation

Starodubtseva, N. L., Chagovets, V., Nekrasova, M. E., Мирзоевна, Н. Н., Tokareva, A., Bourmenskaya, O., Attoeva, D. I., Kukaev, E., Trofimov, D. Y., Евгеньевич, Ф. В., et al. (2022) · Metabolites · doi:10.3390/metabo12060503 · Cited by 10

Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial

Stoler, M. H., Wright, T. C., Parvu, V., Yanson, K. A., Cooper, C. K., & Andrews, J. A. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.01.004 · Cited by 10

Früherkennung des Zervixkarzinoms in Deutschland

Seifert, U., & Klug, S. J. (2014) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1903-2 · Cited by 10

Clinicians' attitude towards changes in Australian National Cervical Screening Program

Yap, D., Liang, X., Garland, S. M., Hartley, S., Gorelik, A., Ogilvie, G. S., Tan, J., Wrede, C. D., & Jayasinghe, Y. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.018 · Cited by 10

Comparison of Xpert ® HPV and Hybrid Capture ® 2 DNA Test™ for detection of high-risk HPV infection in cervical atypical squamous cells of undetermined significance

Rabaan, A. A., Taylor, D. R., Dawamneh, M. F., & Al‐Tawfiq, J. A. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.04.017 · Cited by 10

Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature

Mistro, A. D., Frayle, H., Rizzi, M., Fantin, G. P., Ferro, A. M., Angeletti, P. M., Rossi, P. G., & Altobelli, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172226 · Cited by 10

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan

Tshomo, U., Franceschi, S., Tshokey, T., Tobgay, T., Baussano, I., Tenet, V., Heideman, D. A. M., Snijders, P. J. F., & Clifford, G. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19783 · Cited by 10

The advent of human papillomavirus detection for cervical screening

Morris, B. J. (2019) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000542 · Cited by 10

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease

Babion, I., Strooper, L. M. A. D., Luttmer, R., Bleeker, M. C. G., Meijer, C. J. L. M., Heideman, D. A. M., Wilting, S. M., & Steenbergen, R. D. M. (2019) · Epigenetics · doi:10.1080/15592294.2019.1600390 · Cited by 10

Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening

Ponti, A., Basu, P. S., Ritchie, D., Anttila, A., Carvalho, A. L., Senore, C., Mallafré‐Larrosa, M., Piccinelli, C., Ronco, G., Soerjomataram, I., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32885 · Cited by 10

Rastreio Oncológico – Porquê, Para Quem, Quando e Como

Rodrigues, V. J. L. (2018) · Revista Internacional em Língua Portuguesa · doi:10.31492/2184-2043.rilp2018.34/pp.125-135 · Cited by 9

Mortality due to cervical and breast cancer in health regions of Brazil: impact of public policies on cancer care

Nogueira, M. C., Guerra, M. R., Bustamante-Teixeira, M. T., Silva, G. A. E., Tomazelli, J. G., Duarte, D. D. A. P., Ribeiro, C. M., Naghavi, M., & Malta, D. C. (2024) · Public Health · doi:10.1016/j.puhe.2024.07.034 · Cited by 9

Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries

Nygård, S., Falkenthal, T. E. H., Sture, T., Lynge, E., Elfström, M. K., & Nygård, M. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae584 · Cited by 9

Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples

Keer, S. V., Latsuzbaia, A., Broeck, D. V., Sutter, P. D., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Weyers, S., Arbyn, M., & Vorsters, A. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.02.004 · Cited by 9

Daily self-sampling for high-risk human papillomavirus (HR-HPV) testing

Sanner, K., Wikström, I., Gustavsson, I. M., Wilander, E., Lindberg, J. H., Gyllensten, U. B., & Olovsson, M. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.09.016 · Cited by 9

Genotype-specific prevalence of human papillomavirus infection in asymptomatic Peruvian women: a community-based study

del Valle-Mendoza, J., Becerra-Goicochea, L., Aguilar-Luis, M. Á., Pinillos-Vilca, L., Carrillo‐Ng, H., Silva-Caso, W. G., Palomares-Reyes, C., Taco-Masias, A. A., Aquino-Ortega, R., Tinco-Valdez, C., et al. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05588-7 · Cited by 9

The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review

Amir, S. M., Idris, I., & Yusoff, H. M. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.3.767 · Cited by 9

Effectiveness of Cervical Testing in and outside a Screening Program—A Case-Control Study

Pankakoski, M., Sarkeala, T. M., Anttila, A., & Heinävaara, S. H. (2022) · Cancers · doi:10.3390/cancers14215193 · Cited by 9

The HPV self-collection paradox: boosting cervical cancer screening, struggling with follow-up care

Wang, R., & Coleman, J. S. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00094-4 · Cited by 9

Cervix cytology samples revealed increased methylation of the human markers FAM19A4 / miR124‐2 up to 8 years before adenocarcinoma

Lindroth, Y., Pedersen, L., Alssamaray, J., Berglund, T., Sundqvist, A., Borgfeldt, C., & Forslund, O. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14707 · Cited by 9

Challenging the concept of “risk of malignancy” in cytology

Nikas, I. P., da Silva, R. S., Sousa‐Pinto, B., & Schmitt, F. C. (2023) · Cancer Cytopathology · doi:10.1002/cncy.22787 · Cited by 9

Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2–3 in Thai women infected with high-risk types of human papillomavirus

Srisuttayasathien, M., Kantathavorn, N., Luasiripanthu, T., Petchjorm, S., Samrarn, J., Ittiamornlert, P., Krisorakun, W., Vanichtantikul, A., Wetcho, T., & Saeloo, S. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.01.014 · Cited by 9

Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study

Nonboe, M. H., Napolitano, G. M., Kann, C. E., Andersen, B. S., Bennetsen, M. H., Christiansen, S., Frandsen, A. P., Rygaard, C., Salmani, R., Schroll, J. B., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306044 · Cited by 9

On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening

Tatar, O., Haward, B., Perez, S., Zhu, P., Brotherton, J. M. L., Decker, K., Lofters, A., Mayrand, M., McBride, E., Ogilvie, G. S., et al. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100901 · Cited by 9

Cervical cancer screening in Australia: Past and present

Farnsworth, A. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21642 · Cited by 9

Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women

Granados, R., Tellez‐Safina, H., Solis, I., Mateos, F., Rodríguez-Barbero, J. M., Aramburu, J. A., Huertas, M. A., Bajo, P., Camarmo, E., Corrales, T., et al. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23821 · Cited by 9

Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan

Sasagawa, T., Maehama, T., Osaka, Y., Sakamoto, J., Shibata, T., Fujita, S., Takakura, M., & Takagi, H. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25025 · Cited by 9

Barriers to cervical cancer screening exist despite integrating HIV and gynaecological services for HIV-positive women in Poland

Kowalska, J. D., Wroblewska, A., Ząbek, P., Firląg‐Burkacka, E., Kalinowska, M., Byczot, Z., & Horban, A. (2018) · Ginekologia Polska · doi:10.5603/gp.a2018.0012 · Cited by 9

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

Ruan, G., Song, Y., Dong, B., Mao, X., Lin, F., Kang, Y., Xu, S., Chen, X., Wu, Q., & Sun, P. (2018) · Cancer Management and Research · doi:10.2147/cmar.s169822 · Cited by 9

Cobas 4800 HPV detection in cervical samples of Polish women

Smolarz, B., Samulak, D., Szyłło, K., Makowska, M., Romanowicz, H., Kojs, Z., & Michalska, M. M. (2019) · Współczesna Onkologia · doi:10.5114/wo.2019.85880 · Cited by 9

Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening

Tay, S. K., Lin, L. E., & Goh, R. C. H. (2017) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v46n7p267 · Cited by 9

LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis

Zhang, H., Jin, S., Ji, A., Ma, Y., Zhang, C., Wang, A., & Wang, R. (2021) · Cancer Management and Research · doi:10.2147/cmar.s276629 · Cited by 9

Impact of educational intervention on cervical cancer screening uptake among reproductive age women

Akinola, A. B., & Constance, M. S. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20211280 · Cited by 9

High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer

Yang, R., Ma, M., Yu, S., Li, X., Zhang, J., & Wu, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.742017 · Cited by 9

Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960–2014—A Nationwide Population-Based Study

Sundqvist, A., Moberg, L., Dickman, P. W., Högberg, T., & Borgfeldt, C. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-1323 · Cited by 9

PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women

He, L., Luo, X., Bu, Q., Jin, J., Zhou, S., He, S., Zhang, L., Yu, L., & Hong, X. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2179916 · Cited by 9

The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis

Palmer, M. R., Saito, E., Katanoda, K., Sakamoto, H., Hocking, J. S., Brotherton, J. M. L., & Ong, J. J. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101018 · Cited by 9

Dysregulation of microRNA Expression in Human Cervical Preneoplastic and Neoplastic Lesions

Galamb, Á., Benczik, M., Zinner, B., Vígh, E., Baghy, K., Jeney, C., Kiss, A., Lendvai, G., & Sobel, G. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-014-9871-x · Cited by 9

Should the Annual Pelvic Examination Go the Way of Annual Cervical Cytology?

MacLaughlin, K. L., Faubion, S. S., Long, M. E., Pruthi, S., & Casey, P. M. (2014) · Women s Health · doi:10.2217/whe.14.30 · Cited by 9

Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women

Guo, Y., You, K., Geng, L., & Qiao, J. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-0029-2 · Cited by 9

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

Májek, O., Duskova, J., Dvořák, V., Beková, A., Klimeš, D., Blaha, M., Anttila, A., & Dušek, L. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000236 · Cited by 9

Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France

Thiéry, A., Akladios, C. Y., Fender, M., Séverac, F., & Baldauf, J. (2016) · Journal of Medical Screening · doi:10.1177/0969141316647091 · Cited by 9

Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial

Smith, L., van Niekerk, D., Coldman, A. J., Krajden, M., Franco, E. L., & Ogilvie, G. S. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.04.009 · Cited by 9

The importance of HPV16 in anal cancer prevention

Wieland, U., & Kreuter, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30683-7 · Cited by 9

Profile of the BD HPV OnclarityTM assay

Bottari, F., & Iacobone, A. D. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1622415 · Cited by 11

Cervical Cancer Prevention: New Frontiers of Diagnostic Strategies

Origoni, M., Prendiville, W. J., & Paraskevaidis, E. A. (2015) · BioMed Research International · doi:10.1155/2015/250917 · Cited by 9

HPV-based screening for prevention of invasive cervical cancer

Sideri, M. G., & Igidbashian, S. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60643-7 · Cited by 9

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer

Canfell, K., Smith, M. A., & Bateson, D. J. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51262 · Cited by 9

Self- and physician-collected high-risk human papillomavirus (HPV) testing to detect high-grade cervical lesions among Thai women

Phoolcharoen, N., Areeruk, W., Kantathavorn, N., Tiyayon, J., Chittithaworn, S., Wetcho, T., Satitniramai, S., Khomphaiboonkij, U., Pitakkarnkul, S., Termrungruanglert, W., et al. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004424 · Cited by 8

Surgical Treatment for Early Cervical Cancer in the HPV Era: State of the Art

Palumbo, M., Corte, L. D., Ronsini, C., Guerra, S., Giampaolino, P., & Bifulco, G. (2023) · Healthcare · doi:10.3390/healthcare11222942 · Cited by 9

Cannabis sativa: Cervical cancer treatment- Role of phytocannabinoids-A story of concern

Malabadi, R. B., Sadiya, M. R., Prathima, T. C., Kolkar, K. P., Mammadova, S. S., & CHALANNAVAR, R. K. (2024) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2024.17.2.0076 · Cited by 10

Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes

Ngu, S., Lau, L. S. K., Chan, C. Y., Ngan, H., Cheung, A., & Chan, K. K. (2024) · BMC Public Health · doi:10.1186/s12889-024-18551-5 · Cited by 8

Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico

Aranda-Flores, C. E., Falang, B. M., Gómez-Laguna, L., Gutiérrez, G. G., León, J. M. O., Uribe, M., Cruz, O., & Sørbye, S. W. (2024) · Cancers · doi:10.3390/cancers16132485 · Cited by 8

Human papillomavirus infection and screening strategies

Chen, S.-H., Song, Y., Gan, N., Wang, P., Kang, Y. M., Wang, S., Zu, Y., & Peng, X.-W. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i5.105055 · Cited by 9

Molecular Screening for Cervical Cancer

Martins, T. R., & Levi, J. E. (2025) · Genes · doi:10.3390/genes16091041 · Cited by 8

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women

Llobet, M. O., Gray, P. G., Baussano, I., Elfström, M. K., Eriksson, T., Lagheden, C., Nieminen, P., Söderlund‐Strand, A., Dillner, J., Pimenoff, V. N., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70229 · Cited by 8

Patient compliance with cervical smear surveillance in a shared‐care setting

Tse, K. Y., Lau, S. K., Lui, M. W., Ip, P. P. C., Cheung, A., & Ngan, H. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2016.04.012 · Cited by 8

The Role of Human Papillomavirus in Cervical Cancer

Smolarz, B., Samulak, D., Makowska, M., Romanowicz, H., Kojs, Z., Wójcik, L., & Michalska, M. M. (2019) · International Journal of Cancer and Clinical Research · doi:10.23937/2378-3419/1410125 · Cited by 8

Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme

Carozzi, F., Burroni, E., Confortini, M., Pompeo, G., Bisanzi, S., Cellai, F., Paganini, I., Mantellini, P., Iossa, A., Lelli, L., et al. (2022) · Journal of Medical Screening · doi:10.1177/09691413211067922 · Cited by 9

AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis

Zhu, Y., Feldman, S., Leung, S. O. A., Creer, M. H., Warrick, J. I., Williams, N., & Mastorides, S. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac142 · Cited by 10

Cervical intraepithelial neoplasia in non-16/18 high-risk human papilloma virus positive/cytology negative women: An alternative approach in poor resource areas

Yarandi, F., Shirali, E., Feizabad, E., Ramhormozian, S., Sarmadi, S., SadrAmeli, M., & Arshadi, E. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.12.003 · Cited by 8

Cervical Cancer Screening in Women Aged Older Than 65 Years

Tuncer, S. F., & Tuncer, H. A. (2023) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000742 · Cited by 8

Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study

Onuki, M., Takahashi, F., Iwata, T., Nakazawa, H., Yahata, H., Kanao, H., Horie, K., Konnai, K., Nio, A., Takehara, K., et al. (2023) · Cancer Science · doi:10.1111/cas.15943 · Cited by 8

Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework

Cocuzza, C. E., Dhillon, S. K., Martinelli, M., Giubbi, C., Njoku, R. C., Bhatia, R., Cuschieri, K. S., & Arbyn, M. (2023) · International Journal of Cancer · doi:10.1002/ijc.34754 · Cited by 8

A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches

Gîscă, T., Munteanu, I.-V., Vasilache, I.-A., Melinte-Popescu, A.-S., Volovăț, S. R., Scripcariu, I. S., Balan, R. A., Socolov, R. V., Păvăleanu, I., Cărăuleanu, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051368 · Cited by 8

Current status and challenges in timely detection of cervical cancer in Mexico: expert consensus

Barquet-Muñoz, S. A., Arteaga-Gómez, C., López, E. D., Rodríguez-Trejo, A., Márquez-Acosta, J., & Aranda-Flores, C. E. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1383105 · Cited by 8

Clinically validated HPV assays offer comparable long‐term safety in primary cervical cancer screening: A 9‐year follow‐up of a population‐based screening cohort

Oštrbenk, A., Kroon, K. R., Fabjan, D., Mlakar, J., Seme, K., Berkhof, J. H., & Poljak, M. (2024) · International Journal of Cancer · doi:10.1002/ijc.35200 · Cited by 8

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study

Marco, L. D., Bisanzi, S., Ronco, G., Mancuso, P., Carozzi, F., Allia, E., Rizzolo, R., Gustinucci, D., Frayle, H., Viti, J., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00897-24 · Cited by 8

Human Papillomavirus ( HPV ) Screening With Universal Access to Vaginal Self‐Testing: Outcomes of an Implementation Trial

Sykes, P. H., Innes, C., Bell, R. A. R., Nip, J., McMenamin, J., McBain, L., Hudson, B., Gibson‐Helm, M. E., Whaiti, S. T., Tino, A. B., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18159 · Cited by 8

Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years

Flannelly, G., Mooney, T., Greehy, G. M., Keogh, E. B., McNally, S. A., & Fitzpatrick, P. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000323 · Cited by 8

Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China

Zhang, L., Xie, F., Wang, X., Peng, D., Bi, C., Jiang, L., Zhao, D., Tian, X., & Qi, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180618 · Cited by 8

Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening

Liao, Y., & Li, Q. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1662299 · Cited by 8

Detection and genotyping of human papillomavirus virus (HPV): a comparative analysis of clinical performance in cervical and urine samples in Chilean women.

Buchegger, K., Viscarra, T., Andana, A., Ili, C., López, J., Zanella, L., Carmona-López, M. I., Fernández, J. J., Cartas‐Espinel, I., Sánchez, R., et al. (2018) · Europe PMC (PubMed Central) · Cited by 8

The Performance of Immunocytochemistry Staining as Triaging Tests for High-Risk HPV-Positive Women: A 24-Month Prospective Study

Li, Y., Zhao, Y., Li, T., Chen, W., Liao, G., Wang, H., Lei, H.-K., Guo, Y., & Zhou, Q. (2020) · Journal of Oncology · doi:10.1155/2020/6878761 · Cited by 8

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years

Schroll, J. B., Serizawa, R., & Rebolj, M. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004522 · Cited by 8

Comparison of Different HPV-based Strategies and Cytology in Routine Cervical Cancer Screening Programme in China: A Population-based Study

Wang, S., Li, L., Yang, J., Han, N., Bao, H., & Wang, H. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0104 · Cited by 8

The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study

Xu, H., Liu, Y., Luo, Y., Zhao, D., Jia, M., Chen, P., Li, M., Sun, X.-A., Liu, S., Sun, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.716762 · Cited by 8

Cervical cancer in the era of precision medicine: A perspective from developing countries

Poondla, N., Madduru, D., Duppala, S. K., Velpula, S., Nunia, V., Kharb, S., Ghatak, S., Mishra, A. K., Vuree, S., Neyaz, M. K., et al. (2021) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2021.100015 · Cited by 8

Prognostic factors for squamous cervical carcinoma identified by competing-risks analysis: A study based on the SEER database

Hu, C., Cao, J., Zeng, L., Luo, Y., & Fan, H. C. M. (2022) · Medicine · doi:10.1097/md.0000000000030901 · Cited by 8

Absolute Risk and Attributable Fraction of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions—A Population-Based Study of 6286 Women in Rural Areas of China

Li, L., Jiang, M., Li, T., Yin, J., Feng, R., Dong, L., Imam, S., Cui, J., Liu, B., Zhang, X., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216483 · Cited by 8

Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping

Naegele, K., Weissbach, F. H., Leuzinger, K., Gosert, R., Bubendorf, L., & Hirsch, H. H. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28583 · Cited by 8

Cancer du col utérin : spécificités chez les patientes séropositives pour le VIH

Grellier, N., & Quéro, L. (2014) · Bulletin du Cancer · doi:10.1684/bdc.2014.2034 · Cited by 8

Screening of cervical cancer in Catalonia 2006–2012

de Sanjosé, S. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.532 · Cited by 8

Improving cervical cancer screening in Baltic, central, and eastern European countries

Altobelli, E. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30388-6 · Cited by 8

Stratifying HPV‐positive women for CIN3+ risk after one and two rounds of HPV‐based screening

Veldhuijzen, N. J., Polman, N. J., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30865 · Cited by 8

Discriminating performance of early uterine and cervical artery pulsatility and resistivity in preinvasive cervical lesions

Doğan, O. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2018.07769 · Cited by 8

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624